UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of Microsatellite Status and Pan-Immune-Inflammation Score on Pathological Response in Patients with Clinical Stage III Stomach Cancer Treated with Perioperative Chemotherapy

Medicina (Kaunas, Lithuania), 2023-09, Vol.59 (9), p.1625

2023

Volltextzugriff (PDF)

Panitumumab Associated Acute Pancreatitis

Journal of oncology pharmacy practice, 2022-07, Vol.28 (5), p.1207-1208

2022

Volltextzugriff (PDF)

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

Journal of oncology pharmacy practice, 2024-04, p.10781552241241004-10781552241241004

2024

Volltextzugriff (PDF)

Prevalence of antineutrophil cytoplasmic antibody positivity in patients with Hodgkin’s and non-Hodgkin lymphoma: a single center experience

International journal of hematology, 2009-07, Vol.90 (1), p.52-57

2009

Volltextzugriff (PDF)

Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report

Journal of neuro-oncology, 2007-08, Vol.84 (1), p.103-105

2007

Volltextzugriff (PDF)

Evaluation of antibody response after two doses of the Sinovac vaccine and the potential need for booster doses in cancer patients

Journal of medical virology, 2022-06, Vol.94 (6), p.2487-2492

2022

Volltextzugriff (PDF)

Thrombosis of temporal artery and renal vein in Kimura disease related nephrotic syndrome

Journal of thrombosis and thrombolysis, 2009-01, Vol.27 (1), p.115-118

2009

Volltextzugriff (PDF)

Do the Survival Data of Primary Tumor Resection Provide Sufficient Data Without Considering the Tumor Sidedness, Predictive Biomarkers, and Biologic Agents?

Journal of clinical oncology, 2021-09, Vol.39 (26), p.2970-2970

2021

Volltextzugriff (PDF)

Pembrolizumab (pembro) + chemotherapy (chemo) for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Updated results from the KEYNOTE-859 study

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.4045-4045

2024

Volltextzugriff (PDF)

Hepatitis B virus reactivation induced by Yttrium-90-ibritumomab-tiuxetan

Leukemia & lymphoma, 2007-01, Vol.48 (9), p.1866-1868

2007

Volltextzugriff (PDF)

Alterations in muscle strength among patients with GI cancers receiving oral nutritional support as soon as malnutrition was detected: ONMUS study

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.741-741

2024

Volltextzugriff (PDF)

Prognostic Importance of Inflammatory Indexes in Patients Treated by Pazopanib for Soft Tissue Sarcoma

Clinical laboratory (Heidelberg), 2022-01, Vol.68 (2)

2022

Volltextzugriff (PDF)

KEYNOTE-859 study of pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Outcomes in the protocol-specified PD-L1–selected populations

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4014-4014

2023

Volltextzugriff (PDF)

Optimal use of oral nutritional supplements (ONS) in medical nutrition therapy: ONS consensus report from KEPAN

European journal of clinical nutrition, 2023-07, Vol.77 (7), p.705-709

2023

Volltextzugriff (PDF)

Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study

Journal of thoracic oncology, 2024-02, Vol.19 (2), p.285-296

2024

Volltextzugriff (PDF)

Enteral nutrition consensus report from KEPAN: Indications, choice, practical application and follow-up

Nutrition (Burbank, Los Angeles County, Calif.), 2024-02, Vol.118, p.112269-112269, Article 112269

2024

Volltextzugriff (PDF)

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e15562-e15562

2022

Volltextzugriff (PDF)

Clinical efficacy and safety of the BAT1706 (proposed bevacizumab biosimilar) compared with reference bevacizumab in patients with advanced nonsquamous NSCLC: A randomized, double-blind, phase III study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9041-9041

2022

Volltextzugriff (PDF)

Brigatinib-associated autoimmune hepatitis: A case report

Journal of oncology pharmacy practice, 2023-04, p.10781552231171322-10781552231171322

2023

Volltextzugriff (PDF)

The impact of tamoxifen treatment on voice parameters in premenopausal women with breast cancer

European archives of oto-rhino-laryngology, 2024-02, Vol.281 (2), p.1025-1030

2024

Volltextzugriff (PDF)

Investigation of the change in the biological structure of the tumor in metastatic breast cancer

Medical Science and Discovery, 2021-03, Vol.8 (3), p.171-174

2021

Volltextzugriff (PDF)

Comparison of MRI findings of glioblastoma and gliosarcoma – can conventional MRI provide beneficial differences for diagnosis?

Česká a Slovenská neurologie a neurochirurgie, 2021-06, Vol.84/117 (4)

2021

Volltextzugriff (PDF)

Steatohepatitis due to FOLFIRINOX regimen in adjuvant pancreas cancer treatment mimicking liver metastasis

Journal of oncology pharmacy practice, 2020-10, Vol.26 (7), p.1738-1742

2020

Volltextzugriff (PDF)

Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non‐small cell lung cancer: A randomized, double‐blind, phase III study

Cancer medicine (Malden, MA), 2023-11, Vol.12 (22), p.20847-20863

2023

Volltextzugriff (PDF)

Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre Study

Oncology research and treatment, 2019-10, Vol.42 (10), p.516-522

2019

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(82)
Berichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of Microsatellite Status and Pan-Immune-Inflammation Score on Pathological Response in Patients with Clinical Stage III Stomach Cancer Treated with Perioperative Chemotherapy

Panitumumab Associated Acute Pancreatitis

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

Prevalence of antineutrophil cytoplasmic antibody positivity in patients with Hodgkin’s and non-Hodgkin lymphoma: a single center experience

Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report

Evaluation of antibody response after two doses of the Sinovac vaccine and the potential need for booster doses in cancer patients

Thrombosis of temporal artery and renal vein in Kimura disease related nephrotic syndrome

Do the Survival Data of Primary Tumor Resection Provide Sufficient Data Without Considering the Tumor Sidedness, Predictive Biomarkers, and Biologic Agents?

Pembrolizumab (pembro) + chemotherapy (chemo) for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Updated results from the KEYNOTE-859 study

Hepatitis B virus reactivation induced by Yttrium-90-ibritumomab-tiuxetan

Alterations in muscle strength among patients with GI cancers receiving oral nutritional support as soon as malnutrition was detected: ONMUS study

Prognostic Importance of Inflammatory Indexes in Patients Treated by Pazopanib for Soft Tissue Sarcoma

KEYNOTE-859 study of pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Outcomes in the protocol-specified PD-L1–selected populations

Optimal use of oral nutritional supplements (ONS) in medical nutrition therapy: ONS consensus report from KEPAN

Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study

Enteral nutrition consensus report from KEPAN: Indications, choice, practical application and follow-up

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC

Clinical efficacy and safety of the BAT1706 (proposed bevacizumab biosimilar) compared with reference bevacizumab in patients with advanced nonsquamous NSCLC: A randomized, double-blind, phase III study

Brigatinib-associated autoimmune hepatitis: A case report

The impact of tamoxifen treatment on voice parameters in premenopausal women with breast cancer

Investigation of the change in the biological structure of the tumor in metastatic breast cancer

Comparison of MRI findings of glioblastoma and gliosarcoma – can conventional MRI provide beneficial differences for diagnosis?

Steatohepatitis due to FOLFIRINOX regimen in adjuvant pancreas cancer treatment mimicking liver metastasis

Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non‐small cell lung cancer: A randomized, double‐blind, phase III study

Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre Study

Suchergebnisse filtern